LGND earnings: a positive outcome, +9.8%

On May 8, 2024, Ligand Pharmaceuticals Incorporated reached its earnings. The result was a positive outcome, and the stock moved +9.8% in the window around the event. It had already run -7.2% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.